While high costs and other challenges remain a concern, specialty drugs including biologics and biosimilars should be continually evaluated for potential benefits to injured workers, as they may provide relief that traditional therapies cannot. (Credit: Kenishirotie/Stock.adobe.com)
When we talk about addressing pharmacy issues in workers' compensation programs, opioid concerns often appear at the top of the agenda, and while opioid management remains an important focus, it is not the only pharmacy trend we must watch closely.
Want to continue reading?
Become a Free PropertyCasualty360 Digital Reader
Your access to unlimited PropertyCasualty360 content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- All PropertyCasualty360.com news coverage, best practices, and in-depth analysis.
- Educational webcasts, resources from industry leaders, and informative newsletters.
- Other award-winning websites including BenefitsPRO.com and ThinkAdvisor.com.
Already have an account? Sign In
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
